Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 23, 2011

Primary Completion Date

October 2, 2018

Study Completion Date

October 2, 2018

Conditions
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedRecurrent Cervical Carcinoma
Interventions
BIOLOGICAL

Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (24)

10461

Montefiore Medical Center-Einstein Campus, The Bronx

21215

Sinai Hospital of Baltimore, Baltimore

21287

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

23298

Virginia Commonwealth University/Massey Cancer Center, Richmond

28203

Carolinas Medical Center/Levine Cancer Institute, Charlotte

31404

Memorial Health University Medical Center, Savannah

35233

University of Alabama at Birmingham Cancer Center, Birmingham

43210

Ohio State University Comprehensive Cancer Center, Columbus

44060

UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor

44106

Case Western Reserve University, Cleveland

48109

University of Michigan Comprehensive Cancer Center, Ann Arbor

53226

Froedtert and the Medical College of Wisconsin, Milwaukee

63110

Washington University School of Medicine, St Louis

66160

University of Kansas Cancer Center, Kansas City

73104

University of Oklahoma Health Sciences Center, Oklahoma City

74146

Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa

75390

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

85013

Saint Joseph's Hospital and Medical Center, Phoenix

90033

Los Angeles County-USC Medical Center, Los Angeles

USC / Norris Comprehensive Cancer Center, Los Angeles

92093

UC San Diego Moores Cancer Center, La Jolla

94115

UCSF Medical Center-Mount Zion, San Francisco

94158

UCSF Medical Center-Mission Bay, San Francisco

77555-0565

University of Texas Medical Branch, Galveston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Advaxis, Inc.

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT01266460 - Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer | Biotech Hunter | Biotech Hunter